Sample Size Determination for Interval Estimation of the Prevalence of a Sensitive Attribute Under Randomized Response Models

Autor: Qiu, SF, Tang, ML, Tao, JR, Wong, RS

Publikováno v: Psychometrika. 87(4)

Studies with sensitive questions should include a sufficient number of respondents to adequately address the research interest. While studies with an inadequate number of respondents may not yield significant conclusions, studies with an excess of re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41deb64269e1995fe9c4cd0c2572ee3
https://pubmed.ncbi.nlm.nih.gov/35306631

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection.

Autor: Qiu SF; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China., Zhang QZ; Berry Oncology Corporation, Beijing, 100102, China., Wu ZY; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China., Liu MZ; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China., Ding Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China., Sun FM; Berry Oncology Corporation, Beijing, 100102, China., Wang Y; Berry Oncology Corporation, Beijing, 100102, China; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, 350200, China., Yang HX; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China., Zheng L; Berry Oncology Corporation, Beijing, 100102, China., Chen X; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China., Wu L; Berry Oncology Corporation, Beijing, 100102, China., Bai J; Berry Oncology Corporation, Beijing, 100102, China; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, 350200, China. Electronic address: baijian488@berryoncology.com., Liu JF; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014, China. Electronic address: drjingfeng@fjmu.edu.cn., Chen CB; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China; Fujian Provincial Key Laboratory of Tumor Biotherapy Fuzhou, 350200, China. Electronic address: ccb@fjmu.edu.cn.

Publikováno v: EBioMedicine [EBioMedicine] 2024 Oct; Vol. 108, pp. 105321. Date of Electronic Publication: 2024 Sep 11.

Multiple test procedures of disease prevalence based on stratified partially validated series in the presence of a gold standard.

Autor: Qiu SF; Department of Statistics and Data Science, Chongqing University of Technology, Chongqing, China., Zhang XL; Department of Statistics and Data Science, Chongqing University of Technology, Chongqing, China.; School of Iflytfk Data Science, Chongqing City Vocational College, Chongqing, China., Qu YQ; Department of Statistics and Data Science, Chongqing University of Technology, Chongqing, China.; School of Finance, Chongqing College of Finance and Economics, Chongqing, China., Han YQ; Department of Statistics and Data Science, Chongqing University of Technology, Chongqing, China.

Publikováno v: Journal of biopharmaceutical statistics [J Biopharm Stat] 2024 Aug; Vol. 34 (5), pp. 753-774. Date of Electronic Publication: 2023 Oct 19.